AZN vs JBLU · P/E 28, $288.38B cap vs rev $4.94B
AstraZeneca PLC (AZN) versus JetBlue Airways Corp (JBLU) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
JetBlue Airways Corp (JBLU) is a airlines company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported JBLU revenue for 2026-06-30 was $4.94B. Net income was -$566.0M. JBLU currently screens at market cap $1.77B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. JBLU currently screens at market cap $1.77B.
Not investment advice. Open the AZN and JBLU stock pages for the full models.
Not investment advice.